Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Veelbelovende orale medicatie in ontwikkeling voor anemie bij CKD
jun 2021 | Benigne hematologie, Chronische nierschade